Shenzhen Lifotronic Technology Co., Ltd.

XSSC:688389 Stock Report

Market Cap: CN¥6.8b

Shenzhen Lifotronic Technology Balance Sheet Health

Financial Health criteria checks 5/6

Shenzhen Lifotronic Technology has a total shareholder equity of CN¥1.9B and total debt of CN¥627.0M, which brings its debt-to-equity ratio to 32.2%. Its total assets and total liabilities are CN¥2.8B and CN¥873.8M respectively. Shenzhen Lifotronic Technology's EBIT is CN¥372.7M making its interest coverage ratio -10. It has cash and short-term investments of CN¥1.7B.

Key information

32.2%

Debt to equity ratio

CN¥627.00m

Debt

Interest coverage ratio-10x
CashCN¥1.73b
EquityCN¥1.95b
Total liabilitiesCN¥873.76m
Total assetsCN¥2.82b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 688389's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥870.2M).

Long Term Liabilities: 688389's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥3.5M).


Debt to Equity History and Analysis

Debt Level: 688389 has more cash than its total debt.

Reducing Debt: 688389's debt to equity ratio has increased from 0% to 32.2% over the past 5 years.

Debt Coverage: 688389's debt is well covered by operating cash flow (56.9%).

Interest Coverage: 688389 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies